跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TGXIME - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
TGXIME
Approved
STANDARD
TGXIME
Scott-Edil Advance Research Laboratories & Education Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
990e834a378e3681
Company
Scott-Edil Advance Research Laboratories & Education Limited
Type
Standard
Approval Details
Approval Id
990e834a378e3681
Drug Approval Philippines Name
TGXIME
Product Name
TGXIME
Registration Number
DRP-5121-14
Brand Name
TGXIME
Generic Name
Cefixime (as trihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Scott-Edil Advance Research Laboratories & Education Limited
Importer
Pharmakon Biotec Inc
Distributor
TGIF Pharmaceutical Trading Inc.
Issuance Date
24 April 2024
Expiry Date
14 October 2028
Pharmacologic Category
Antibacterial (Third Generation Cepahlosporin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
990e834a378e3681
Type
Standard
Back to Philippines FDA Approvals